M&A Deal Summary |
|
|---|---|
| Date | 2011-07-05 |
| Target | Aegis Lightwave |
| Sector | Electronics |
| Buyer(s) | Coherent |
| Sellers(s) | Alta Partners |
| Deal Type | Add-on Acquisition |
| Deal Value | 52M USD |
| Advisor(s) | Bowen (Financial) |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1971 |
| Sector | Test/Measurement Equipment |
| Employees | 26,000 |
| Revenue | 5.2B USD (2023) |
Coherent provides engineered materials and opto-electronic components and is a vertically integrated manufacturing company that develops innovative products for diversified applications in the industrial, optical communications, military, life sciences, semiconductor equipment, and consumer markets. Coherent was founded in 1971 and is based in Saxonburg, Pennsylvania.
| DEAL STATS | # |
|---|---|
| Overall | 4 of 13 |
| Sector (Electronics) | 1 of 1 |
| Type (Add-on Acquisition) | 3 of 11 |
| State (Massachusetts) | 1 of 1 |
| Country (United States) | 2 of 8 |
| Year (2011) | 1 of 1 |
| Size (of disclosed) | 5 of 8 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-12-07 |
Max Levy Autograph
Philadelphia, Pennsylvania, United States Max Levy Autograph, Inc. is a manufacturer of half-tone screens and etched plates for the graphic arts industry. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-11-01 |
M Cubed
Newtown, Connecticut, United States M Cubed develops and markets advanced composite products to original equipment manufacturers in semiconductor, display, industrial, and defense markets worldwide. |
Buy | $71M |
| Category | Venture Capital Firm |
|---|---|
| Founded | 1996 |
| PE ASSETS | 2.6B USD |
| Size | Large |
| Type | Sector Focused |
Alta Partners is a venture capital firm that targets investments in early and later stage life science companies, including biopharmaceuticals, medical technology, and information technology businesses. Alta was formed as an early stage investor but has since expanded its investment range to provide later stage growth capital to private and young public companies. Alta was established in 1996 and is headquartered in San Francisco, California.
| DEAL STATS | # |
|---|---|
| Overall | 51 of 84 |
| Sector (Electronics) | 2 of 2 |
| Type (Add-on Acquisition) | 36 of 45 |
| State (Massachusetts) | 6 of 7 |
| Country (United States) | 44 of 74 |
| Year (2011) | 5 of 7 |
| Size (of disclosed) | 22 of 23 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-03-28 |
ChemGenex Pharmaceuticals
Menlo Park, California, United States ChemGenex Pharmaceuticals is a pharmaceutical development company dedicated to improving the lives of patients by developing personalized therapeutics in the areas of oncology, diabetes and obesity. ChemGenex’s lead compound, Ceflatonin®, is currently in Phase 2/3 clinical trials for chronic myeloid leukemia and Quinamed® is in Phase 2 clinical trials for several solid cancers. ChemGenex's pipeline also includes several pre-clinical stage anti-diabetes lead mole. |
Sell | $231M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-11-02 |
Talphera
San Mateo, California, United States Talphera is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain. Talphera was founded in 2005 and is headquartered in Hayward, California. |
Sell | - |
